Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Severe Depressive Episode: Prospective, Multicentric, Comparative, Single Blind Clinical Investigation. EMC1 Study

NCT06601140 is registered in ClinicalTrials.gov with Emobot as lead sponsor.

NCT NCT06601140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06601140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Severe Depressive Episode: Prospective, Multicentric, Comparative, Single Blind Clinical Investigation. EMC1 Study
Lead sponsor
Emobot
Phase
Not applicable
Overall status
Recruiting
Start date
March 5, 2025
Completion date
February 4, 2027
Enrollment
104 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder (mdd)